Mid-Cap Biotechs Lead the Market: Pre-ASCO Scoreboard…Updates 6/4/18
6/4/18...after close Update-2...IBB down 0.65%, XBI down 0.22%. Momentum Waning Big Winners Today : BLUE, FMI, GHDX, IMMU, MRK It would appear that biotech stocks need to be bought prior to ASCO as has been then trend in the past i.e sell before the news. However there will be some clear cut...
Financial and Political Crisis in Italy Disrupts Biotech Stock Momentum…Updates with rally today 5/30
Updates 5/30 Pre-ASCO Rally: XBI regains momentum to $94 level. IBB breaks through SMA 200 level to $108+. Many mid-caps from our watch list soaring-CRSP*, FMI, FOLD, LGND, LOXO, NKTR, SGEN, SRPT etc. *Note CRSP got whacked after hours down 13 points! The FDA has put the clinical trial for...
Biotech Mid-Caps: The Momentum Trade is Back FMI, LOXO,XBI etc
Biotech Mid-Caps- Momentum Trade is Back ASCO Abstracts Provide Clinical Updates But as of 2 P EDT Stocks Are Being Hit By Profit Taking XBI at $92.39 Biotech mid-caps had a good week ending 5/18 as tracked by the top performing XBI which was up 2% and over 10% in 2018 YTD. The large cap...
Biotechs Soar After Big Trump Drug Price Speech- Mid-Caps Should Outperform…Updates
Update: 5/17...Mini-Rally Continues With Help From ASCO Abstracts XBI hits $93.78 above April highs, up 5.32% over 5 days, 10.5% YTD. IBB at April highs at $107.59, up 3.62% over 5 days, up 0.77% YTD Many Mid-Caps are hot: BLUE, CRSP, EXEL, FOLD, LGND, LOXO. See our list below. Gene editing...
Biotech Stocks Underperform Market: CELG, EXEL, PBYI, XBI…Updates 5/11…Big Rally on Drug Pricing Speech
Trump Speech on Plan for Lower Drug Prices 5/11 After close. Biotech and healthcare stocks were broadly higher. Key words by HHS Secretary were "complex" and "will take time"; more updates tomorrow. General objectives appear to be to lower list prices and squeeze middlemen like PBMs, offer...